Patents by Inventor Philip Wendell Jones

Philip Wendell Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors
    Patent number: 10570156
    Abstract: Provided herein are cyclic nucleotide phosphodiesterase inhibitors of Formula (I) of claim 1, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: February 25, 2020
    Assignee: SUNOVION PHARMACEUTICALS INC.
    Inventors: John Emmerson Campbell, Philip Wendell Jones, Michael Charles Hewitt
  • HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20180072759
    Abstract: Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
    Type: Application
    Filed: November 20, 2017
    Publication date: March 15, 2018
    Inventors: John Emmerson Campbell, Philip Wendell Jones, Michael Charles Hewitt